Position
Fidelity in Biomarin Pharmaceutical Inc
Back to the book · All holders of BMRN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $2.6M$56.49 → $57.22
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.84M | $109.2M | — | — | — | 0.0% |
| Q1 2026 | 3.57M | $201.5M | $56.49 | −$5.4M | $97.7M | 0.0% |
| Q2 2026 | 4.82M | $276M | $57.22 | $2.6M | $71.9M | 0.0% |